After digitalisation, the next global wave of transformation is rolling in - the Bio Revolution. To bring in a change from a linear, fossil-based economy to a sustainable, bio-based economy within which the European bioeconomy will play a decisive role, Luxembourg-based impact fund European Circular Bioeconomy Fund (ECBF) has raised around €300 million.
The fund will finance growth companies in the bioeconomy and biobased circular economy. Originally set for €250 million, the EU-backed fund is backed by investors, including Landwirtschaftliche Rentenbank, Allianz France, Invest NL, GC, Firmenich, Stellar Impact (a vehicle managed by Telos Impact, Dr. Hans-Riegel Holding, Bellevue Investments and companies such as Neste, Nestlé, BÜFA, NRW.BANK, Volkswohl Bund, Corbion, Dr. Hettich Beteiligungen, Koehler Group and Wortmann Family Office. The group of investors now includes 25 shareholders.
The money will be invested exclusively into growth companies in the bioeconomy and the biobased circular economy that commits to environmental, social, and governance (ESG) integration.
While visionary founders often lack the necessary growth capital to scale their solutions internationally, the ECBF will close the financing gap in cooperation with private and public investors. Investors from 8 countries are backing the mission of the ESG fund
Michael Brandkamp, co-founder and managing partner of ECBF said: “Exceeding our initial target of €250 million is a big commitment for us. With the necessary expertise, strong dedication of the ECBF team and the right partners, we can make our vision of a bio-based economy a reality. Many European founders have enormous potential to help ride the wave of the Bio Revolution, and we will do our utmost to support them. This is the only way we can significantly support a sustainable economy - and thus a secure future for all.”